Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Gramtec Studio AB
AB
Active
Org 5594210345
Norrgatan 16, 432 41
Varberg
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2023 · 3 years old
1 employees
Overvåg
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Gramtec Studio AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
18
26
Staff expenses
—
—
EBITDA
−137
−109
Depreciation & amort.
−0
−0
EBIT
−137
−109
Net financials
—
—
Profit before tax
−137
136
Tax
−0
−1
Net profit
−137
135
Balance sheet
SEK thousands
Item
2024
2025
Total assets
139
209
Equity
53
188
Long-term debt
0
0
Short-term debt
86
20
Total debt
86
20
Financial ratios
5-year trend
EBITDA-margin
-419.2%
This company
15.8%
Market median
-2753% vs market
2024
2025
Soliditetsgrad
90.0%
This company
38.2%
Market median
+136% vs market
2024
2025
Egenkapitalforrentning
71.8%
This company
18.4%
Market median
+290% vs market
2024
2025
Nettoresultatgrad
519.2%
This company
8.1%
Market median
+6310% vs market
2024
2025
Aktivomsætning
0.12×
This company
1.12×
Market median
-89% vs market
2024
2025
Gæld/egenkapital
0.11×
This company
0.62×
Market median
+82% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-04-30
View
PDF
More on Gramtec Studio AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
